Only 11 of 17 products selected for testing met quality criteria for freshness and labeling
Concept of benign myalgic encephalomyelitis
How to Interpret a Neurotransmitter Test
Jun 07, 2026, 17:30 ET CagriSema, a once-weekly investigational treatment that combines a novel amylin analog with a GLP-1 receptor agonist (RA), achieved significant reductions in HbA 1c and bodyweight versus comparators across three phase 3 trials in adults with type 2 diabetes (T2D) 1-3 Data from the REIMAGINE clinical development program, a series of phase 3 trials evaluating once-weekly CagriSema in adults with T2D across various stages of their disease, were presented at an ADA symposium 1-3 Novo Nordisk continues to demonstrate pioneering leadership and scientific innovation through advancing diabetes research PLAINSBORO, N.J
Allergic reactions: Rare but requires vigilance
Recalls & Warnings May 06, 2017 Herbal Teas Recalled Due To Botulism Risk On May 1, 2017, U.S